Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DRB18 is a highly effective pan-class inhibitor of glucose transporter proteins (GLUT). It significantly modulates energy-related metabolism in A549 cells by inducing alterations in the abundance of metabolites associated with glucose-related pathways. DRB18 exerts its effects by promoting G1/S phase arrest, increasing oxidative stress, and prompting necrotic cell death, ultimately displaying notable anti-tumor activity [1].
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 965 | 现货 | ||
5 mg | ¥ 2,390 | 现货 | ||
10 mg | ¥ 3,820 | 现货 | ||
25 mg | ¥ 6,230 | 现货 | ||
50 mg | ¥ 8,560 | 现货 | ||
100 mg | ¥ 11,500 | 现货 | ||
500 mg | ¥ 22,900 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 2,430 | 现货 |
产品描述 | DRB18 is a highly effective pan-class inhibitor of glucose transporter proteins (GLUT). It significantly modulates energy-related metabolism in A549 cells by inducing alterations in the abundance of metabolites associated with glucose-related pathways. DRB18 exerts its effects by promoting G1/S phase arrest, increasing oxidative stress, and prompting necrotic cell death, ultimately displaying notable anti-tumor activity [1]. |
体外活性 | DRB18 (0-10 μM; 30 min) reduces glucose uptake in GLUT1-4-expressed HEK293 cell lines in a dose-dependent manner with IC 50 s varying from ~ 900 nM to ~ 9 μM [1]. DRB18 (5 and 10 μM; 72 hours) results in cell cycle arrest in the G1/S phase transition [1]. DRB18 (5 and 10 μM; 72 hours) increases ROS levels in A549 cells [1]. DRB18 (5 and 10 μM; 72 hours) reduces expression of glycosylated GLUT1 and GLUT2-4 in A549 cells in a dose-dependent manner [1]. Cell Proliferation Assay Cell Line: GLUT1-4-expressed HEK293 cell lines [1] Concentration: 0-10 μM Incubation Time: 30 min Result: Reduced glucose uptake in these cell lines in a dose-dependent manner with IC 50 s varying from ~ 900 nM to ~ 9 μM. Cell Cycle Analysis Cell Line: A549 [1] Concentration: 5 and 10 μM Incubation Time: 72 hours Result: Caused cell cycle arrest in the G1/S phase transition. Western Blot Analysis Cell Line: A549 [1] Concentration: 5 and 10 μM Incubation Time: 72 hours Result: Reduced expression of glycosylated GLUT1 and GLUT2-4 in A549 cells in a dose-dependent manner. Western Blot Analysis Cell Line: A549 [1] Concentration: 5 and 10 μM Incubation Time: 72 hours Result: Reduced expression of glycosylated GLUT1 and GLUT2-4 in A549 cells in a dose-dependent manner. |
体内活性 | DRB18 (10 mg/kg; IP; thrice a week for 5 weeks) significantly inhibits tumors volume by 44% and tumors weight by 43% [1]. Animal Model: Male NU/J nude mice (3-4 weeks; tumor cell-injected) [1] Dosage: 10 mg/kg Administration: IP; thrice a week for 5 weeks Result: The tumors were 44% smaller by volume and 43% smaller by weight, also showed DRB18 decreased expression of GLUT1-4 (Fig. 5f) and reduced proliferative capacity within the xenografted tumor. |
分子量 | 382.88 |
分子式 | C22H23ClN2O2 |
CAS No. | 2863686-81-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (117.5 mM), Sonication and heating to 60℃ are recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.6118 mL | 13.0589 mL | 26.1178 mL | 65.2946 mL |
5 mM | 0.5224 mL | 2.6118 mL | 5.2236 mL | 13.0589 mL | |
10 mM | 0.2612 mL | 1.3059 mL | 2.6118 mL | 6.5295 mL | |
20 mM | 0.1306 mL | 0.6529 mL | 1.3059 mL | 3.2647 mL | |
50 mM | 0.0522 mL | 0.2612 mL | 0.5224 mL | 1.3059 mL | |
100 mM | 0.0261 mL | 0.1306 mL | 0.2612 mL | 0.6529 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
DRB18 2863686-81-9 Metabolism transporter DRB 18 DRB-18 Inhibitor inhibitor inhibit